Meitav Dash Investments LTD Red Hill Biopharma Ltd. Transaction History

Meitav Dash Investments LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$4.6 - $8.6 $59,799 - $111,800	-13,000 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$3.51 - $6.17 $45,630 - $80,210	13,000 New	13,000 $57,000
Q4 2019 Feb 10, 2020	SELL	$5.76 - $7.35 $83,520 - $106,575	-14,500 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$6.06 - $9.0 $215,130 - $319,500	-35,500 Reduced 71.0%	14,500 $123,000
Q4 2018 Feb 13, 2019	BUY	$5.18 - $9.35 $6,702 - $12,098	1,294 Added 2.66%	50,000 $278,000
Q3 2018 Nov 14, 2018	BUY	$6.0 - $11.35 $4,236 - $8,013	706 Added 1.47%	48,706 $422,000
Q4 2017 Feb 15, 2018	BUY	$4.58 - $10.81 $219,840 - $518,880	48,000	48,000 $244,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.